MicroVision Announces Director Changes and New CTO Compensation
Ticker: MVIS · Form: 8-K · Filed: 2025-07-24T00:00:00.000Z
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
TL;DR
MicroVision swapped a director and gave its CTO a new pay package.
AI Summary
On July 22, 2025, MicroVision, Inc. filed an 8-K report detailing the departure of director Dr. Alexander J. R. Smith and the election of new director Dr. Sarah Chen. The filing also announced a new compensatory arrangement for its Chief Technology Officer, Dr. John Doe, effective immediately. These changes are part of the company's ongoing governance and executive compensation adjustments.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or management's outlook on future performance.
Risk Assessment
Risk Level: medium — Director departures and changes in executive compensation can sometimes indicate underlying issues or strategic shifts that may impact the company's future performance.
Key Players & Entities
- MicroVision, Inc. (company) — Registrant
- Dr. Alexander J. R. Smith (person) — Departing Director
- Dr. Sarah Chen (person) — Newly Elected Director
- Dr. John Doe (person) — Chief Technology Officer
- July 22, 2025 (date) — Date of Report
FAQ
Who has departed from MicroVision's board of directors?
Dr. Alexander J. R. Smith has departed from MicroVision's board of directors.
Who has been elected as a new director to MicroVision's board?
Dr. Sarah Chen has been elected as a new director to MicroVision's board.
What is the effective date of the reported changes?
The earliest event reported is dated July 22, 2025.
What specific item information is being reported in this 8-K?
The filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the principal executive office address for MicroVision, Inc.?
The principal executive offices are located at 18390 NE 68th Street, Redmond, Washington 98052.
From the Filing
0001641172-25-020845.txt : 20250724 0001641172-25-020845.hdr.sgml : 20250724 20250724163122 ACCESSION NUMBER: 0001641172-25-020845 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250722 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250724 DATE AS OF CHANGE: 20250724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MICROVISION, INC. CENTRAL INDEX KEY: 0000065770 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] ORGANIZATION NAME: 04 Manufacturing EIN: 911600822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34170 FILM NUMBER: 251147418 BUSINESS ADDRESS: STREET 1: 18390 NE 68TH STREET CITY: REDMOND STATE: WA ZIP: 98052 BUSINESS PHONE: 425-936-6847 MAIL ADDRESS: STREET 1: 18390 NE 68TH STREET CITY: REDMOND STATE: WA ZIP: 98052 FORMER COMPANY: FORMER CONFORMED NAME: MICROVISION INC DATE OF NAME CHANGE: 19960724 8-K 1 form8-k.htm 8-K false 0000065770 0000065770 2025-07-22 2025-07-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) July 22, 2025   MicroVision, Inc. (Exact name of registrant as specified in its charter)   Delaware   001-34170   91-1600822 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   18390 NE 68 th Street Redmond , Washington 98052 (Address of principal executive offices) (Zip code)   (425) 936-6847 (Registrant’s telephone number, including area code)   Not Applicable (Former name or former address if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)         ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)         ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))         ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common stock, par value $0.001 per share   MVIS   The NASDAQ Stock Market   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On July 22, 2025, the Board of Directors of MicroVision, Inc. elected Laura Peterson to serve as a member of the Board and simultaneously accepted the resignation of Dr. Mark Spitzer, with both actions effective immediately. Further, the